- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03144492
Microgravity Effects on Co-cultured Vascular Cells Types
February 19, 2020 updated by: University of Florida
The goal of this study is to assess the affect of ground based microgravity on co-cultured vascular cell types.
Our goal is to better understand the cross-talk between vascular cell types grown under conditions such as microgravity as is seen in space.
In this pilot study, the investigator proposes to assess changes in cell phenotype and function in microgravity as compared to normal gravity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study builds upon previously reported space flight data in GenLab, as well as our own published data whereby the investigator evaluate the effect of microgravity on the differentiation and functional potential of circulating stem cells.
The goal of this work is to leverage the powerful genetic analyses done in the SPHINX study and look at the consequences these changes have on cell-cell communications essential for vascular homeostasis, for a possible correlation to cardiovascular deconditioning.
The application of this work is targeted at possible "cell based" countermeasures to address the negative effects of microgravity on the vasculature.
Study Type
Observational
Enrollment (Actual)
2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- University of Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The Study team is interested in sampling a wide variety of health individuals from varying ethnic groups, sex, and age range.
Description
Inclusion Criteria:
- Self-reported healthy individuals
- Willingness to have 50mls of whole blood collected
Exclusion Criteria:
- Unwillingness to have blood used in stem cell research
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
self-reported healthy individuals
Self-reported healthy individuals avoiding blood draw on the days participants are feeling "under the weather"or sick.
In that case, study team can delay the blood draw until the subject feels better, but this would not preclude anyone from participating.
|
The subject will be sitting in a chair, and a needle will be inserted into a vein in their arm.
Study Team will draw about 45ml or 3 tablespoons of whole blood for research.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differentiation (Colony Forming) Kinetics of normal vs microgravity cultured stem cells
Time Frame: Within 4 weeks of collecting cells
|
The study team are interesting in the effect of co-cultured Endothelial cells on the kinetics of stem cell colony formation (i.e.
differentiation).
As compared to normal gravity samples, the colonies that form while in co-culture with ECs will be counted and monitored.
This gives a measure of the differentiation potential of these cells.
|
Within 4 weeks of collecting cells
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gene and Protein expression of normal vs microgravity cultured stem cells
Time Frame: through study completion, up to 2 years from the start of the study
|
The study team will use rtPCR to probe the stem cells for the up regulation of Endothelial cell (EC) specific genes and down regulation of stem cell genes.
EC specific genes include vascular endothelial cadherin (CD144), platelet endothelial cell adhesion molecule (PECAM), and von Willebrand factor (vWF).
Stem cell markers include CD34.
The study team will use GAPDH as a control.
|
through study completion, up to 2 years from the start of the study
|
|
Anti-thrombogenic function of normal vs microgravity cultured stem cells
Time Frame: through study completion, up to 2 years from the start of the study
|
The study team will utilize platelet adhesion and blood clotting assays to assess any changes in how anti-thrombogenic the differentiated endothelial cells are.
|
through study completion, up to 2 years from the start of the study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 26, 2017
Primary Completion (ACTUAL)
February 1, 2020
Study Completion (ACTUAL)
February 1, 2020
Study Registration Dates
First Submitted
May 2, 2017
First Submitted That Met QC Criteria
May 5, 2017
First Posted (ACTUAL)
May 8, 2017
Study Record Updates
Last Update Posted (ACTUAL)
February 20, 2020
Last Update Submitted That Met QC Criteria
February 19, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB201700297
- 16-2016GL_FP-0011 (OTHER_GRANT: National Aeronautics and Space Administration)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microgravity Exposed Endothelial Cells
-
Sohag UniversityRecruitingCorneal Endothelial CellsEgypt
-
Taipei Veterans General Hospital, TaiwanNational Yang Ming UniversityCompletedEndothelial Progenitor Cells Numbers | Endothelial Function (FMD)Taiwan
-
University of MinnesotaCompletedExercise Tolerance | Endothelial CellsUnited States
-
Heinrich-Heine University, DuesseldorfCompletedEndothelial Function | Red Blood Cells | Nitric Oxide Pool in Red Blood Cells and Blood PlasmaGermany
-
General University Hospital, PragueUniversity of IowaUnknownHemodynamics | Tomography, Optical Coherence | Coronary Circulation | Endothelial Cells | Polymorphism, GeneticCzech Republic
-
University Clinic FrankfurtEnrolling by invitationCorneal Biomechanics | Tomography | Optical Coherence Tomography | Endothelial Cells | IOP | Manifest RefGermany
-
Azienda Socio Sanitaria Territoriale degli Spedali...Janssen Diagnostics, LLCCompletedEndothelial Dysfunction | Graft vs Host Disease | Complications of Organ Transplant Stem CellsItaly
-
General and Teaching Hospital CeljeCompletedDiabetes Mellitus, Type 1 | Biomarkers | Endothelial Dysfunction | Arterial Stiffness | FMD | Incretins | Endothelial Progenitor Cells | SGLT 2 Inhibitors | Glucose Excursions | FPFSlovenia
-
Lawson Health Research InstituteHamilton Health Sciences Corporation; London Health Sciences CentreCompletedClear Cell Renal Cancer | Circulating Tumor Cells | Predictive Biomarkers | Prognostic Biomarkers | Circulating Endothelial CellsCanada
-
University of EdinburghBritish Heart FoundationCompletedCoronary Artery Disease | Coronary Angiography | Vascular Injury | Endothelial Progenitor CellsUnited Kingdom
Clinical Trials on Blood volume collected specifically for this study
-
University of FloridaFlorida Space InstituteCompletedCardiovascular DiseasesUnited States
-
University of FloridaFlorida Space InstituteWithdrawn
-
Assistance Publique - Hôpitaux de ParisCompletedAnaphylactic Shock to Neuro-Muscular Blocking Agents (NMBA)France
-
British Columbia Cancer AgencyM.D. Anderson Cancer Center; University of Texas at AustinCompleted
-
Virginia Commonwealth UniversityCompleted
-
Maastricht University Medical CenterUnknown
-
Laval UniversityCanadian Institutes of Health Research (CIHR)UnknownChronic Obstructive Pulmonary DiseaseCanada
-
Istituto Auxologico ItalianoRecruiting
-
Laval UniversityCanadian Institutes of Health Research (CIHR)UnknownChronic Obstructive Pulmonary DiseaseCanada